GMP CDMO Eurogentec operates as a GMP biomanufacturer and FDA/EMA-aligned CDMO with capabilities in process development, scale-up, and manufacturing of proteins, plasmids, and vaccines, presenting a sales opportunity for end-to-end contract manufacturing and tech transfer services for biotech partners.

Genomics and Proteomics With strong offerings in genomics and proteomics, including oligonucleotides, PCR/qPCR kits, peptides, antibodies, and assay reagents, there is potential to upsell custom reagents, assay development services, and bespoke kit solutions to life sciences and diagnostic customers.

Regulatory Readiness Certified ISO 9001 and ISO 13485 and approved by US FDA for commercial biologics indicate a robust quality and regulatory framework, enabling Eurogentec to target regulated markets and partner companies requiring compliant manufacturing and supply of GMP-grade materials.

Strategic Partnerships Being part of Kaneka Corporation and having historical collaborations positions Eurogentec well for co-development, technology licensing, and strategic partnerships that broaden product portfolios and accelerate market reach in Europe and beyond.

Diagnostics and IVD In vitro diagnostics capabilities for GMP oligonucleotides and Taq polymerases open sales avenues with diagnostic developers, vaccine manufacturers, and molecular testing labs seeking reliable reagents and contract manufacturing support.